Testosterone versus hCG in Hypogonadotropic Hypogonadism - Comparing Clinical Effects and Evaluating Current Practice

• Auteurs principaux: Swashti Agarwal MD (Auteur), Duong D. Tu MD (Auteur), Paul F. Austin MD (Auteur), Michael E. Scheurer PhD (Auteur), Lefkothea P Karaviti MD, PhD (Auteur)
• Format: Livre
• Publié: SAGE Publishing, 2020-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background. Gonadotropin therapy is not typically used for pubertal induction in hypogonadotropic hypogonadism (HH), however, represents a promising alternative to testosterone. It can potentially lead to the maintenance of future fertility in addition to testicular growth. We compared the pubertal...